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Abstract
Primary open angle glaucoma affects more than 67 million people. Elevated intraocular pressure (IOP) is a risk factor for
glaucoma and may reduce nutrient availability by decreasing ocular perfusion pressure (OPP). An interaction between
arterial blood pressure and IOP determines OPP; but the exact contribution that these factors have for retinal function is not
fully understood. Here we sought to determine how acute modifications of arterial pressure will affect the susceptibility of
neuronal function and blood flow to IOP challenge. Anaesthetized (ketamine:xylazine) Long-Evan rats with low
(,60 mmHg, sodium nitroprusside infusion), moderate (,100 mmHg, saline), or high levels (,160 mmHg, angiotensin
II) of mean arterial pressure (MAP, n=5–10 per group) were subjected to IOP challenge (10–120 mmHg, 5 mmHg steps
every 3 minutes). Electroretinograms were measured at each IOP step to assess bipolar cell (b-wave) and inner retinal
function (scotopic threshold response or STR). Ocular blood flow was measured using laser-Doppler flowmetry in groups
with similar MAP level and the same IOP challenge protocol. Both b-wave and STR amplitudes decreased with IOP elevation.
Retinal function was less susceptible to IOP challenge when MAP was high, whereas the converse was true for low MAP.
Consistent with the effects on retinal function, higher IOP was needed to attenuated ocular blood flow in animals with
higher MAP. The susceptibility of retinal function to IOP challenge can be ameliorated by acute high BP, and exacerbated by
low BP. This is partially mediated by modifications in ocular blood flow.
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Introduction
Glaucoma is the second leading cause of blindness in those of
working age and is characterized by a progressive death of the
cells that make up the optic nerve [1]. The most well
documented risk factor for glaucoma is elevated eye pressure
(intraocular pressure, IOP). Elevated IOP is thought to cause
retinal damage by mechanical and vascular mechanisms. The
vascular compromise is thought to occur through direct
compression of blood vessels in the optic nerve head and retina.
When IOP elevation reduces ocular perfusion pressure (OPP)
beyond the capacity for autoregulation, ocular blood flow will
become compromised leading to retinal dysfunction. Since OPP
represents a balance between mean arterial pressure and IOP
(OPP=MAP2IOP), it is likely that a reduction in systemic
blood pressure (BP) or a comparable increase in IOP will have
similar effects on retinal function. Thus, for a given IOP
elevation, retinal dysfunction should be exacerbated by low BP,
but ameliorated by high BP.
Several studies suggest that blood pressure plays an important
role in glaucoma. More specifically, nocturnal hypotension may
exacerbate the progression of visual field loss in patients with
glaucoma [2–4]. It is thought that when a nocturnal BP dip
coincides with an IOP spike, a substantial OPP reduction produces
an intermittent insult that increases the risk of disease progression
[5]. In agreement with this hypothesis low BP has consistently
been found to be a risk factor in glaucoma [6–15]. However,
epidemiological studies offer equivocal conclusions as to whether
systemic hypertension reduces glaucoma risk. A number of large
scale epidemiological trials report a lower risk of glaucoma in
individuals with elevated blood pressure [12,15–17], whereas
others [13,18–21] have found the opposite. This suggests that the
influence of systemic hypertension on glaucoma is complex [22].
On the one hand, one might expect high BP to improve OPP and
provide protection against IOP elevation. On the other hand,
systemic hypertension may be complicated by vascular dysfunc-
tion, which may counteract any protective effect afforded by high
BP.
Given the above, a better understanding of how IOP and BP
interact to influence retinal function is needed. An acute
experimental approach that affords accurate simultaneous control
of both IOP and BP is useful as it avoids long term cardiovascular
confounds. Few studies have measured retinal function during
simultaneous manipulation of IOP and BP [23,24]. To date, no
study has measured retinal function and blood flow during IOP
and BP manipulation. Thus the aim of this study is to evaluate
retinal function and blood flow over a wide range of OPPs,
induced by IOP elevation in rats with low, moderate and high
levels of acutely modified BP.
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Subjects
All experimental procedures were in compliance with the
ARVO Statement for the Use of Animals in Ophthalmic and
Vision Research and the NHMRC Australian Code of Practice for
the care and use of animals for scientific purposes. Animal ethics
approval was obtained from the Animal Ethics Committee,
Science Faculty, University of Melbourne. Animals used in this
study were male Long-Evans rats (aged 10–15 weeks, 300–400 g,
Monash Animal Service, Clayton, VIC, Aust). Rats were housed
in a 12-hour light (50 lux) /12-hour dark environment with
normal rat chow and water available ad libitum. All experimental
procedures were conducted under general anaesthesia (ketami-
ne:xylazine, 60:5 mg/kg, im). As ketamine is known to affect blood
pressure in rodents [25], care was taken to standardise the
anaesthesia regimen and duration in all animals. A topical
anaesthetic (proxymetacaine 0.5% eye drops) and mydriatic
(0.5% tropicamide) was given as necessary.
Acute IOP elevation
To assess ocular susceptibility across a gradient of OPPs,
animals underwent stepwise IOP elevation from 10 to 120 mmHg
(increment of 5 mmHg for 3 min) while MAP was held stable at
low, moderate or high level (Figure 1). Each BP cohort was
subdivided into two groups to measure either retinal function or
ocular blood flow during IOP challenge. In the functional assay,
IOP was raised manometrically by vitreal chamber cannulation,
whereas in the blood flow assay, IOP was raised manometrically
by anterior chamber cannulation. Vitreal chamber cannulation
was chosen during functional assay to avoid interference with the
placement of electroretinogram (ERG) electrodes on the cornea.
Anterior chamber cannulation was used for ocular blood flow
measurement to allow placement of a 26G laser-Doppler
flowmetry (LDF) probe in the vitreal chamber. A pilot study
showed that both vitreal and anterior chamber cannulations
produce the same level of IOP elevation (Figure S1). Following
cannulation, the desired IOP was achieved by placing a saline
reservoir at a precalibrated height.
Blood pressure monitoring and manipulation
Blood pressure was monitored via an indwelling cannula in the
left femoral artery. Blood pressure was modulated by pharmaco-
logical intervention. Blood pressure reduction and elevation was
achieved by variable infusion into the femoral vein of sodium
nitroprusside (SNP, 84 mmol/ L in 0.9% saline, Sigma Aldrich,
Castle Hill, Australia) and angiotensin II (AngII, 10 mmol/L in
0.9% saline, Auspep, Parkville, Australia), respectively.
To cannulate the femoral arteries and veins, the left groin area
was shaved and disinfected with 70% ethanol. The left femoral
artery and vein were exposed with a 2 cm skin incision and
separated from the surrounding connective tissue by blunt
dissection. A small incision was made through the arterial wall.
A heparinised polyethylene cannula (inner and outer diameter
0.28 and 0.61 mm respectively) was inserted 3 cm proximally into
the femoral artery. The exterior end of the cannula was connected
to a pressure transducer (Transpac, Abbott Critical Care Systems,
Sligo, IRE) to give direct and continuous BP monitoring.
Using the same method, the femoral vein was also cannulated,
which allowed systemic BP to be maintained at low, moderate and
high levels by infusion of SNP (2.5%; 50–250 mg/kg/min), normal
saline (5 ml/min) or AngII (1%; 45–90 mg/kg/min), respectively.
The rate of infusion was constantly adjusted within these ranges
using an electronic syringe pump (HA22I, Harvard Apparatus,
MA, USA) to produce a stable BP level during the simultaneous
stepwise IOP elevation (Figure 1). The average MAP in the
functional assay was 6362, 10063, and 16164 mmHg (low,
moderate and high BP groups respectively), which are similar to
the groups used for the blood flow (5962, 10864 and
15665 mmHg; p=0.934, two-way ANOVA). As MAP was
Figure 1. Blood pressure during experimental manipulations. Experimental protocol for stepwise IOP elevation in animals with acute high,
moderate and low blood pressure. MAP (mean 6 SEM) was held stable during IOP elevation. In each blood pressure group, animals were assigned to
either functional (white symbols) or blood flow assay (grey symbols). MAP levels in animals in the functional assay were similar to their counterparts
in the blood flow assay (p.0.05).
doi:10.1371/journal.pone.0031104.g001
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assays, the two outcome measures could be directly compared,
despite being obtained from different cohorts of animals.
While one eye underwent IOP challenge, the fellow eye served
as control with IOP set manometrically to 10 mmHg via vitreal
chamber cannulation. Retinal function was found to remain
unchanged in these sham control eyes (Figure S2). This suggests
that, under current experimental conditions, SNP and AngII
infusion do not affect retinal function.
In this study, OPP is calculated as the difference between mean
arterial pressure and IOP (OPP=MAP2IOP), which differs
slightly from the relationship used in humans (OPP=2/3
MAP2IOP). The ‘2/3’ MAP adjustment factor is only applicable
to primates in an upright position and therefore not incorporated
here, as rat OPP is measured in a supine position. This estimate of
OPP for rats is consistent with previous estimates from pigs [26],
cats [27,28] and rabbits [29].
Retinal function: electroretinography
To quantify retinal susceptibility to IOP challenge, scotopic
electroretinograms (ERG) were recorded at each IOP step. In
rodents, the scotopic b-wave reflects rod bipolar cell function [30],
and the scotopic threshold response (STR) is representative of
retinal ganglion cells [31,32]. The ganglion cell contribution to the
STR has been established in previous studies of experimental
glaucoma [33–35], optic nerve transection [31], as well as those
using pharmacological agents [31,32,36] and behavioral ap-
proaches [37]. One limitation of the STR is that its signal-to-
noise ratio is smaller than the b-wave. To address this issue, the
STR recorded at each IOP step represents an average of 20
repeats.
Prior to functional measurement, animals were dark-adapted
overnight (12 hours). To maintain dark-adaptation, all procedures
including simultaneous acute IOP elevation and BP manipulations
were performed in darkness with the aid of night vision goggles
(NVMT24021, Yukon Advanced OpticsH, USA) and an infra-red
light source (L=880 nm, 18 LED IR Spotlight). Anaesthetized
rats were placed on a heated platform. The active electrode
(custom-made chlorided silver electrode) was placed on the cornea,
and the ring-shaped reference electrode positioned around the
limbus. The ground electrode was inserted subcutaneously in the
tail. At each IOP step, a pair of stimuli of 21.12 and 25.25 log
cd.s.m
22 was presented via a Ganzfeld integrating sphere
(Photometric Solutions International, VIC, Aust), which elicited
the b-wave and the STR (STR averaged over 20 repeats),
respectively. Signals were digitized at 4 kHz with 61000
amplification and a band-pass of 0.3 to 1000 Hz (23 dB). Both
b-wave and STR were quantified in terms of the peak-to-trough
amplitude.
Ocular blood flow: laser-Doppler flowmetry
Laser-Doppler flowmetry (LDF; ML191, ADInstruments Pty
Ltd, NSW, Australia) was employed to measure ocular blood flow
by inserting an invasive needle probe (MNP110XP, ADInstru-
ments) into the vitreal chamber. The working principle of LDF
and its applications in the eye are detailed elsewhere [38–41].
Briefly, a Doppler frequency shift of the incident laser light is
produced by moving blood cells but not by static tissue. Within a
given measurement volume, this Doppler shift is processed to
derive blood flow. Prior to IOP elevation, a small puncture was
made at the 12 o’clock position, 1 mm posterior to the limbus
using a 22G needle, which provides access for the LDF probe into
the vitreal chamber. Using a micromanipulator (KITE, World
Precision Instruments, FL, USA), the tip of the LDF probe was
inserted 2 mm intravitreally pointing towards the retina. The
measurement depth of the LDF probe is 1 mm [42], which in rats
reflects a weighted average of both retinal and choroidal blood
flow (Figure S3). Therefore, the term ‘‘ocular blood flow’’ is used
throughout this study.
Normalization of relative ocular blood flow
For any given eye, the LDF provides a reliable intra-subject
comparison and is excellent for continuous blood flow monitoring,
which makes it ideal for assessing a relative change in response to
IOP challenge [43]. To allow for inter-subject comparison
between blood pressure groups, baseline flow (IOP=10 mmHg)
in different groups was compared by characterizing the effect of
MAP variation on ocular blood flow. A full MAP-flow curve was
collected in a separate group of animals (n=5) with IOP kept at
10 mmHg. More specifically, blood flow was measured over a
wide range of MAPs (25–165 mmHg) by using a combination of
renal and coeliac artery ligation to produce hypertension, followed
by variable SNP infusion to produce hypotension. This curve was
used to determine the baseline blood flow for each animal prior to
IOP elevation. Blood flow measured during IOP challenge, was
then normalized to each animals adjusted baseline.
Data analysis
All group data were expressed as mean 6 SEM. At baseline,
ERG and LDF measurements were found to be normally
distributed (Kolmogorov-Smirnov normality statistics) with equal
variance. ERG amplitudes were also expressed relative to baseline
(IOP of 10 mmHg). The relationship between IOP and relative
retinal function (b-wave and STR amplitude) was described using
a cumulative normal function [33],
y~1{
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where, relative retinal function (y, %) is described as a function of
IOP (x, mmHg). The parameter s indicates the steepness of the
curve, whereas IOP50 represents the IOP for a 50% reduction in
retinal function, which provides a measure of susceptibility to IOP
elevation. To consider the association between blood pressure and
function or blood flow susceptibility to IOP challenge, the
correlation between MAP and IOP50 was examined with a
Deming regression, which is a robust method of regression that
accounts for the variability in both axes (MAP and IOP50).
Equation 1 was also fitted to relative retinal function plotted
against OPP, where OPP50 is the index of susceptibility.
Results
Influence of blood pressure on functional susceptibility
to IOP
Figure 2 shows individual examples of ERG b-wave (Panels A
and C) and STR (Panels B and D) responses recorded during
simultaneous BP and IOP manipulation. At baseline IOP,
waveforms in the hypotensive rat (MAP 63 mmHg, thick traces,
Panels A and B) were similar to those in the control (MAP
101 mmHg, thin traces) despite differences in BP. The effect of BP
becomes manifest as IOP increases. In particular, the b-wave and
STR were reduced to a greater extent in the hypotensive when
compared with the normotensive rat.
The same control animal (moderate MAP, 101 mmHg) shown
in Figures 2A and 2B (thin traces) was replotted in Figures 2C and
2D, to allow comparison with a hypertensive animal (MAP
Ocular Perfusion Pressure and the Retina
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e31104156 mmHg, thick traces). Baseline b-wave and STR in the
hypertensive rat were not different to the control. IOP elevation
produces less dysfunction in the hypertensive rat. This was
especially evident at 100 mmHg, where retinal function was
abolished in the normotensive rat (MAP 101 mmHg,
OPP,0 mmHg) but preserved in the hypertensive animal (MAP
156 mmHg, OPP 56 mmHg).
Figure 3 shows the group data (mean 6 SEM) for absolute and
relative ERG amplitude as a function of IOP. At baseline IOP
(10 mmHg), absolute b-wave and STR amplitudes were similar
between the three BP groups (p=0.881 and 0.720 for Figures 3A
and 3D, respectively; one-way ANOVA), indicating that neither
changes in MAP (from 63 to 161 mmHg) nor the pharmacological
agents per se (AngII and SNP) had any detectable effect on the
ERG. Therefore b-wave and STR amplitude were normalized to
their own baseline (Figures 3B and 3E). When comparing BP
groups, the IOP-response curve gradually shifts rightward with
increasing MAP (interaction p,0.001 for both Figures 3B and 3E,
two-way RM ANOVA), meaning that retinal function was more
resistant to IOP as BP increased.
The susceptibility of retinal function to elevated IOP was
quantified using a cumulative normal function (Equation 1, curves
in Figures 3B and 3E), which returns the IOP for 50% dysfunction
(IOP50, arrow in Figure 3B). As shown in Figures 3C and 3F,
individual IOP50 for both b-wave and STR amplitude increased
proportionately with MAP. Deming regressions showed a
significant correlation with a slope of less than 1 (p,0.001 for
both Figures 3C and 3F). A positive correlation between MAP and
IOP50 indicates that hypertension increases the ability of neurons
to resist IOP insult. However, a slope of less than unity suggests
that MAP elevation does not fully compensate for the retinal
dysfunction induced by the same amount of IOP elevation. This
issue is better illustrated when retinal function is plotted against
OPP (Figure 4).
If OPP were the sole determinant of retinal function then
relative function for all three blood pressure groups should overlie
Figure 2. Effect of blood pressure on ERG waveforms during IOP elevation. Representative ERG b-wave and STR (to 21.12 and 25.25 log
cd.s.m
22 stimuli, respectively) showing the effect of low BP (A&C , thick traces, MAP 63 mmHg) and high BP (B&D , thick traces, MAP 156 mmHg)
on retinal susceptibility to IOP elevation. Overlaid with the hypo- and hypertensive responses is that from a control rat with moderate blood pressure
(thin traces, MAP 101 mmHg).
doi:10.1371/journal.pone.0031104.g002
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response functions clearly did not overlie each other. Moreover,
when modeled with a cumulative normal function (Equation 1,
curves in Figure 4), the OPP50 (the OPP for 50% functional loss)
should be the same for all animals regardless of blood pressure.
However, this was not the case. The presence of a significant
positive correlation between OPP50 and MAP (Figures 4B and 4D,
Deming regression, all p,0.05) shows that function in the
hypertensive group was not as well protected as one might expect
from the OPP improvement, whereas for the low BP group
susceptibility was not as bad as anticipated from the change in OPP.
Influence of blood pressure on vascular susceptibility to
IOP
To consider whether the retinal dysfunction found during OPP
changes (Figures 2 to 4) was mediated by blood flow, Figure 5
compares the IOP-flow relationships for high, moderate and low
BP groups. Unlike the functional study (Figure 3) where baseline
ERG in all groups could be normalized to 100%, baseline ocular
blood flow varies with BP and therefore cannot be set to the same
level. Figure 5A shows that baseline ocular blood flow increased
with MAP elevation, except at an intermediate level where there
was a plateau, consistent with autoregulation. This curve provides
a means to determine the starting point for blood flow in the three
different BP groups. At baseline IOP (10 mmHg), the average
MAP for the low, moderate and high BP groups was 59, 108 and
156 mmHg, which corresponds to a relative blood flow of 78%,
116% and 204%, respectively (arrows in Figure 5). Here 100%
represents the normal pre-manipulation condition (IOP
10 mmHg, MAP 9363 mmHg). Figure 5B shows that relative
ocular blood flow when plotted as a function of IOP (Figure 5B)
was shifted to higher IOPs in animals with acute high BP, and to
lower IOPs in animals with low BP (interaction, p,0.001, two-
way RM ANOVA).
Comparing functional and blood flow response to OPP
As summarized in Figure 6, both retinal function and blood flow
were progressively reduced with lower levels of OPP, achieved
with high IOP or low MAP. However, retinal function and ocular
blood flow clearly did not decline at the same rate. At low and
moderate MAP, retinal function remained relatively preserved
despite substantial IOP-induced blood flow deficiency, suggesting
that a ‘‘functional reserve’’ protects against relative ischemia.
However, the relationship between function and blood flow was
reversed in the high BP group. Retinal function begins to decline
when IOP was at 60 mmHg, but blood flow was still well above
baseline. This outcome suggests that retinal function has a ceiling
and does not improve with hyper-perfusion.
Discussion
Effect of OPP on retinal function
A key finding of this study was that OPP (determined by BP and
IOP) substantially influences retinal function. In animals with low
BP, milder IOP elevations were needed to compromise retinal
function compared with controls. In contrast, animals with an
acute increase in BP endured a greater IOP challenge before
retinal dysfunction occurred (Figure 3). These results confirm
previous studies which have found that bipolar cell function,
measured with the ERG b-wave [24], and ganglion cell function,
Figure 3. Effect of BP on the susceptibility of retinal function to IOP elevation. Given that baseline function was similar between low,
moderate and high BP groups, the absolute amplitudes of b-wave (A) and STR (D) are also expressed relative (B & E) to their own baselines. Curves:
cumulative normal function (Equation 1). Arrow: definition of IOP50 as the IOP for 50% ERG deficit. Error bars: SEM. Relationships between individual
IOP50 and MAP for b-wave (C) and STR (F) are modelled using a Deming regression.
doi:10.1371/journal.pone.0031104.g003
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[24], were affected by the balance between BP and IOP.
Therefore, OPP is a more important determinant of neuronal
function, than IOP alone.
In addition, the current study extends previous work [23,24] to
show that retinal susceptibility to a common IOP challenge
(quantified as IOP50) is linearly related to BP (Figures 3C and 3F).
However, OPP was not the only determinant of retinal function.
Figure 4. Relationship between retinal function and ocular perfusion pressure. Retinal function (mean & SEM) is plotted as a function of
OPP for various BP groups. Data for b-wave (A) and STR (C) are reproduced from Figures 3B and 3E respectively. Curves: cumulative normal function
as per Figure 3 (Equation 1). Arrow: definition of OPP50 as the OPP for 50% functional deficit. Relationship between individual OPP50 and MAP was
correlated with Deming regression (lines in B&D ).
doi:10.1371/journal.pone.0031104.g004
Figure 5. Effect of BP on the susceptibility of ocular blood flow to IOP elevation. Relative ocular blood flow (6 SEM) during MAP (A, fixed
IOP) and IOP manipulation (B, fixed MAP). Data in A shows characteristics of blood flow autoregulation as evident by a relative plateau at
intermediate MAPs. As LDF does not measure absolute flow, the autoregulation curve in A is used to set the starting blood flow level for the three
blood pressure groups (arrows in B). Thus all data are effectively normalized to a ‘‘normal’’ baseline condition (in A, IOP 10 mmHg, MAP 9363 mmHg,
n=5).
doi:10.1371/journal.pone.0031104.g005
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the relationship between IOP50 and MAP (Figures 3C and 3F)
would have returned a unity line. In fact, a slope of less than one
showed that as BP increased, the increment in IOP50 was less than
expected based solely on OPP. In other words, MAP elevation
cannot fully compensate for the retinal dysfunction induced by the
same amount of IOP elevation. This was somewhat counterintu-
itive given that OPP, by definition, contains the same contribution
from MAP and IOP (i.e. OPP=MAP2IOP).
That IOP is more important than BP in determining retinal
function was further illustrated in Figure 4, wherein retinal
function plotted against OPP did not collapse to a single curve.
That is, for a given OPP, the higher IOP elevation induced greater
retinal dysfunction. This is possibly because BP modification
influences vascular supply only, whereas an IOP elevation affects
the vascular supply via a reduction in OPP, and produces
mechanical stress on retinal neurons that is OPP independent.
Although previous studies [23,24] have also assessed retinal
function during IOP and BP manipulation, those studies did not
independently compare the influence of BP and IOP. To our
knowledge, this is the first study to show that IOP is more
important than BP in determining retinal function for a given
OPP.
Comparing retinal function and ocular blood flow
Measurement of ocular blood flow by laser Doppler indicates
that the IOP-flow relationship was rightward shifted with
increasing BP (Figure 5B), indicating that BP modifies suscepti-
bility to IOP challenge. This finding agrees with previous studies of
ocular blood flow as recently reviewed by Schmidl and colleagues
[44]. In particular, Kiel and van Heuven [29] showed in rabbit
eyes that it took more IOP elevation to reduce choroidal blood
flow as MAP increased (20 to 80 mmHg). The current study
extends their observations to include higher MAPs (108 and
156 mmHg). More recently, Liang and colleagues [45] also
showed that IOP-induced ischemia at monkey optic nerve head is
exacerbated by systemic hypotension (MAP 56 mmHg).
As it is technically difficult to monitor retinal function and blood
flow simultaneously whilst concurrently manipulating IOP and
BP, we adopt an alternate approach. We measured these outcomes
in separate groups of animals under closely matched experimental
conditions (same IOP and similar MAP modifications, Figure 1).
Figure 6 showed that BP modifies vascular (filled bars) and
functional (unfilled bars) susceptibility to IOP elevation in a similar
way. This suggests that the protection afforded by acute high BP
on retinal function is in part mediated by improved blood flow.
That retinal function was relatively preserved despite substantial
blood flow reduction (Figure 6) provides evidence for a ‘‘functional
reserve’’ [22]. One mechanism that could underlie this functional
reserve is a capacity to increase oxygen extraction from residual
arterial blood during mild ischemia, which helps to maintain tissue
oxygenation [22]. With low perfusion pressure it would be
predicted that erythrocyte transit would be slower and oxygen
extraction may be increased.
The current study sought to understand basic retinal physiology
in terms of functional and hemodynamic response to OPP stress,
therefore only acute IOP and BP manipulations were employed.
Interpretation of our findings in the context of chronic diseases
such as glaucoma and essential hypertension requires caution. In
future studies, it will be of interest to examine the effect of chronic
hypertension on the susceptibility to IOP challenge.
Summary
In summary, the susceptibility of retinal function to IOP
challenge can be partially ameliorated by acute high BP, and
exacerbated by low BP. The mechanism behind this change can
be partly attributed to alterations in OPP and its effects on ocular
blood flow. We find that retinal function can be normal even when
Figure 6. Comparison of relative retinal function and ocular blood flow during IOP elevation. Data for animals with acute low, moderate,
and high BP are re-plotted here. Black circles: blood flow autoregulation curve at baseline IOP (reproduced from Figure 5A). Function (unfilled bars,b -
wave amplitude) is normalized to baseline. Starting blood flow (filled bars) is adjusted based on the autoregulation curve. Bars represent mean + SEM.
doi:10.1371/journal.pone.0031104.g006
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additional compensatory mechanism, possibly related to the
capacity to regulate oxygen extraction. Interestingly, IOP
elevation produces more dysfunction than does BP reduction of
the same magnitude. This difference is likely to reflect the potential
for IOP to produce both vascular insufficiency and mechanical
stress on retinal neurons.
Supporting Information
Figure S1 Comparison of IOP elevation induced by
anterior and posterior chamber cannulation. Both
anterior (A) and vitreal chamber (B) show a strong and similar
linear relationship with IOP elevation induced via anterior
chamber cannulation.
(TIF)
Figure S2 Effect of SNP, saline and AngII on retinal
function. Relative retinal function remained stable in the sham
control eye (IOP=10 mmHg) during continuous infusion of SNP
(A & D), saline (B & E) or AngII (C & F) to sustain low, moderate
or high blood pressure. Time ‘‘0’’ represents the beginning of
stepwise IOP elevation in the fellow eye. A, B & C: relative b-wave
amplitude; D, E & F: relative STR amplitude; Shaded area: 95%
confidence intervals for b-wave and STR amplitudes at time ‘‘0’’.
(TIF)
Figure S3 Effect of 100% O2 breathing on ocular blood
flow. Backscatter (A), MAP (B) and ocular blood flow (C)
were measured before, during and after100% oxygen
breathing. Error bars: SEM; n=6. Shaded area: duration
(2 minutes) of 100% oxygen administration. Dashed line: baseline
blood flow (100%).
(TIF)
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